Enzyme Advising Group believes that only by conceiving new products and services in which a new business model is defined with the participation of artificial intelligence, will applications less focused on optimizing processes and, consequently, reducing jobs, be achieved. In this way, new products and Services will be created, previously impossible to be conceptualized and which will become generators of new opportunities.
Enzyme Advising Group is a consultancy made up of more than 100 professionals, including scientists who are experts in algorithmics and quantum computing, technologists, application and user interface experts, among others. It is one of the leaders in Spain in the application of sophisticated technological solutions, with more than 15 years of experience in fields such as artificial intelligence, ‘blockchain’, ‘Big Data’, ‘Computer Vision’ techniques or ‘ Chatbots’.
Now Enzyme plans to focus on the technology consulting and development of new products and services markets, as well as the structuring and consolidation of various corporate ‘spin offs’ that allow the commercial development of some of its applications with external partners.
The focus goes through an eminently practical vision of the knowledge acquired over the years by the company, focusing on market projects that contribute profitability to the operating account of its clients, with the application of new technologies in the short term and without that they have to pay a learning cost for its application.
Enzyme maintains two areas of research and knowledge generation through collaboration with technology centers and participation in different European projects: quantum computing and the development of different precision medicine tools through artificial intelligence with the Roche laboratories and the Hospital Clínic from Barcelona.
Thus, with the aim of consolidating itself in the technology sector, Enzyme Advising Group is organized into three main divisions:
Over the years, the Enzyme teams have been able to structure and maintain a solid client portfolio, including companies such as Cellnex, Tele Medicine, Hospital Clínico, Hipra, Puig, Dentaid, Volkswagen Group, Central Lechera Asturiana, Grupo Jorge, Vodafone, General Óptica, Catalana de Occidente or Banco Sabadell, among others. Enzyme Advising Group focuses its scope of operation on the Spanish, Portuguese, German, Swiss and Austrian markets.
The expert and consultant, Antoni Flores, has recently been appointed top executive of the company. Flores has more than 30 years of experience in the management of consulting companies, being one of the pioneers in Spain in the application of knowledge, product development and strategic innovation applied to new business models, products and services.
